573 filings
8-K
APTO
Aptose Biosciences Inc
6 May 24
Regulation FD Disclosure
4:45pm
8-K
APTO
Aptose Biosciences Inc
1 May 24
Entry into a Material Definitive Agreement
4:30pm
8-K
APTO
Aptose Biosciences Inc
26 Apr 24
Entry into a Material Definitive Agreement
7:30am
8-K
APTO
Aptose Biosciences Inc
5 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:05pm
8-K
APTO
Aptose Biosciences Inc
26 Mar 24
Aptose Reports Results for the Fourth Quarter and Full Year 2023
4:04pm
8-K
mdk4vg3h
18 Mar 24
Regulation FD Disclosure
4:45pm
8-K
bqv j260h
1 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
qj6 jdt6y
31 Jan 24
Regulation FD Disclosure
4:02pm
8-K
zp43awiquacwsz90j
29 Jan 24
Entry into a Material Definitive Agreement
9:44pm
8-K
y8fcacfero1yuif8jwl3
26 Jan 24
Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical
8:00am
8-K
jrkldb7xk9d
11 Dec 23
Aptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting
6:30am
8-K
pszheyu55yck2im8
30 Nov 23
Aptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive Role
5:28pm
8-K
ivhfh7u3 i6toljcz0r4
9 Nov 23
Aptose Reports Results for the Third Quarter 2023
4:15pm
8-K
kstsazj
2 Nov 23
Aptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual Meeting
9:15am
8-K
zdzghey1
30 Oct 23
Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug Tuspetinib
9:20am
8-K
tjqmef53
26 Oct 23
Regulation FD Disclosure
10:12am
8-K
rek4oy20
23 Oct 23
Aptose to Hold Clinical Update and KOL Data Review of AML Drug Tuspetinib on Monday, October 30th
8:00am
8-K
kb7 kcqk0an
16 Oct 23
Aptose Clinical and Preclinical Data to be Presented at European School of Haematology (ESH) 6th International Conference
8:00am
8-K
05rd d18dbfkev4jx8
18 Sep 23
Aptose to Present at the Cantor Global Healthcare Conference
8:00am
8-K
gqv4u7 f4i
12 Sep 23
Entry into a Material Definitive Agreement
4:30pm